Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Wolfert

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Andrology|September 11, 1998
Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serumL S Grauer, J A Finlay, S D Mikolajczyk, et al.
The Prostate|January 1, 1996
Dual monoclonal antibody immunoassay for free prostate-specific antigenT J Wang, T M Hill, R L Sokoloff, et al.
Cancer Research|November 11, 1998
Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell lineL S Grauer, K D Lawler, J L Marignac, et al.
Journal of Immunological Methods|June 24, 1994
Enhanced immunogenicity of leucine enkephalin following coupling to anti-immunoglobulin and anti-CD3 antibodiesT L Hendrickson, G S Wilson, J M Frazer, et al.
Urology|October 24, 1997
Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assayW J Ellis, R L Vessella, J L Noteboom, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2000
Western blotting analysis of antibodies to prostate-specific antigen: specificities for prostate-specific antigen and prostate-specific antigen fragmentsT J Wang, H J Linton, R L Sokoloff, et al.
JAMA|October 18, 1995
Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screeningW J Catalona, D S Smith, R L Wolfert, et al.
Urology|August 12, 1999
Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative modelW J Catalona, A W Partin, J A Finlay, et al.
British Journal of Cancer|September 4, 2008
Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panelK Oikonomopoulou, L Li, Y Zheng, et al.
Clinical Chemistry|October 7, 1998
The precursor form of the human kallikrein 2, a kallikrein homologous to prostate-specific antigen, is present in human sera and is increased in prostate cancer and benign prostatic hyperplasiaM S Saedi, T M Hill, K Kuus-Reichel, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Andrology|September 11, 1998
Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serumL S Grauer, J A Finlay, S D Mikolajczyk, et al.
The Prostate|January 1, 1996
Dual monoclonal antibody immunoassay for free prostate-specific antigenT J Wang, T M Hill, R L Sokoloff, et al.
Cancer Research|November 11, 1998
Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell lineL S Grauer, K D Lawler, J L Marignac, et al.
Journal of Immunological Methods|June 24, 1994
Enhanced immunogenicity of leucine enkephalin following coupling to anti-immunoglobulin and anti-CD3 antibodiesT L Hendrickson, G S Wilson, J M Frazer, et al.
Urology|October 24, 1997
Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assayW J Ellis, R L Vessella, J L Noteboom, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2000
Western blotting analysis of antibodies to prostate-specific antigen: specificities for prostate-specific antigen and prostate-specific antigen fragmentsT J Wang, H J Linton, R L Sokoloff, et al.
JAMA|October 18, 1995
Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screeningW J Catalona, D S Smith, R L Wolfert, et al.
Urology|August 12, 1999
Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative modelW J Catalona, A W Partin, J A Finlay, et al.
British Journal of Cancer|September 4, 2008
Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panelK Oikonomopoulou, L Li, Y Zheng, et al.
Clinical Chemistry|October 7, 1998
The precursor form of the human kallikrein 2, a kallikrein homologous to prostate-specific antigen, is present in human sera and is increased in prostate cancer and benign prostatic hyperplasiaM S Saedi, T M Hill, K Kuus-Reichel, et al.
Pageof 4